This topic contains a solution. Click here to go to the answer

Author Question: The struggle that comes from not having had a secure base to venture flexibly into new relationships ... (Read 150 times)

Diane

  • Hero Member
  • *****
  • Posts: 576
The struggle that comes from not having had a secure base to venture flexibly into new relationships is:
 
  A) a symptom of life stressors.
  B) typical of clients without a safe haven.
  C) palpable in clients severely bounds by shoulds.
  D) None of the choices are correct.

Question 2

When a therapist and client collaborate to explore and clarify how completely a client's sense of self depends on their ability to achieve or please:
 
  A) the therapist helps the client challenge their assumptions.
  B) the therapist is cataloging inadequacies.
  C) the therapist is revealing the anxious insecurities and emotional deprivations that originally led to the defensive coping strategy.
  D) the therapist is enacting a countertransference issue.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ahnyah

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

C

Answer to Question 2

C





 

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library